AP

Ashay Pramod Karpe

Active Director Director DIN 07766359
DIN 07766359 First appointment Jun 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jun 2017
Shareholding value •••• Premium profile

About Ashay Pramod Karpe

Data last updated:

Ashay Pramod Karpe is a Director at Sunact Cancer Institute Private Limited (since 2023), Director at Shree Saisamarth Healthcare Private Limited (since 2022) and Director at Sunriseonco Foundation (since 2026), and holds 1 more current directorship. The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹28.33 Cr; the largest is Sunact Cancer Institute Private Limited at ₹21.19 Cr (FY 2025). Earlier, Ashay Pramod Karpe was a Designated Partner at Shree Saisamarth Healthcare Llp (from 2017) and Designated Partner at Midas Lifecare International Llp (from 2021).

DIN 07766359
Primary Designation Director
Industry Healthcare
First Appointment 28 Jun 2017
Oldest Company Age 9 yrs
Largest company Sunact Cancer Institute Private Limited · ₹21.19 Cr (FY 2025)
Combined revenue ₹28.33 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Nov 20232023₹21.19 Cr (FY 2025)Active
Director11 Jan 20222022₹7.14 Cr (FY 2025)Active
Sunriseonco Foundation U86909MH2026NPL465465
Director12 Jan 20262026Active
Director22 Nov 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner28 Jun 20172017Converted To Cmp And Dissolved
Designated Partner30 Apr 20212021Converted And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shree Saisamarth Healthcare Private Limited
Shree Saisamarth Healthcare Llp
Midas Lifecare International Llp
Sunriseonco Foundation
Premium access

Shareholding and investment profile for Ashay Pramod Karpe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashay Pramod Karpe

Ashay Pramod Karpe currently holds 4 directorships: Sunact Cancer Institute Private Limited (Director, since 30 Nov 2023, revenue ₹21.19 Cr (FY 2025)); Shree Saisamarth Healthcare Private Limited (Director, since 11 Jan 2022, revenue ₹7.14 Cr (FY 2025)); Sunriseonco Foundation (Director, since 12 Jan 2026); Midas Lifecare International Private Limited (Director, since 22 Nov 2023).

Ashay Pramod Karpe was first appointed on 28 Jun 2017 as Designated Partner at Shree Saisamarth Healthcare Llp. The most recent appointment on record is 12 Jan 2026 at Sunriseonco Foundation.

The 2 current companies of Ashay Pramod Karpe that report revenue have a combined latest revenue of ₹28.33 Cr: Sunact Cancer Institute Private Limited ₹21.19 Cr (FY 2025); Shree Saisamarth Healthcare Private Limited ₹7.14 Cr (FY 2025).

Ashay Pramod Karpe held 2 earlier board appointments: Shree Saisamarth Healthcare Llp (Designated Partner, from 28 Jun 2017); Midas Lifecare International Llp (Designated Partner, from 30 Apr 2021).

The current boards of Ashay Pramod Karpe's companies include Ajay Kotwani (Sunact Cancer Institute Private Limited), Kushagra Sharma (Sunact Cancer Institute Private Limited), Patil Maruti (Sunact Cancer Institute Private Limited), Rahul Bhasin (Sunact Cancer Institute Private Limited), Sampada Dessai (Sunact Cancer Institute Private Limited), Girish Vijaykumar Korde (Shree Saisamarth Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available